BMED
EquityACTIVE

iShares Health Innovation Active ETF

NAV as ofJun 18, 2026
$28.3952 WK: 24.20 - 31.95
1 Day NAV Change as ofJun 18, 2026
Decrease $-0.01(-0.05%)
NAV Total Return as ofJun 17, 2026
YTD: Decrease -5.95%
Unsubsidized 30-Day SEC Yield as ofMay 31, 2026
0.44%
30 Day SEC Yield as ofMay 31, 2026
0.66%
12m Trailing Yield as ofMay 31, 2026
0.00%
Expense Ratio:Fees as stated in the prospectus
0.77%
Net Expense Ratio:Fees as stated in the prospectus
0.55%
Morningstar Medalist Rating
Bronze Medal
NAV as ofJun 18, 2026
$28.3952 WK: 24.20 - 31.95
1 Day NAV Change as ofJun 18, 2026
Decrease $-0.01(-0.05%)
NAV Total Return as ofJun 17, 2026
YTD: Decrease -5.95%
Unsubsidized 30-Day SEC Yield as ofMay 31, 2026
0.44%
30 Day SEC Yield as ofMay 31, 2026
0.66%
12m Trailing Yield as ofMay 31, 2026
0.00%
Expense Ratio:Fees as stated in the prospectus
0.77%
Net Expense Ratio:Fees as stated in the prospectus
0.55%
Morningstar Medalist Rating
Bronze Medal

The iShares Health Innovation Active ETF seeks to maximize total return by actively investing in innovative and emerging companies in the healthcare sector. The fund offers a way to access potential growth from transformative healthcare breakthroughs through fundamental research.

Key Facts

Net Assets of Fund
Closing Price
Daily Volume
Exchange
NYSE Arca
Shares Outstanding
360,000
as of Jun 18, 2026
Premium/Discount
-0.02%
as of Jun 17, 2026
30 Day Avg. Volume
1,313.00
as of Jun 17, 2026
Fund Launch Date
Sep 29, 2020
Asset Class
Equity
Distribution Frequency
Semi-Annual
CUSIP
09290C400
Non-FV NAV
28.39
as of Jun 18, 2026
30 Day Median Bid/Ask Spread
0.32%
as of Jun 17, 2026

Portfolio Characteristics

Number of Holdings
30 Day SEC Yield
12m Trailing Yield
Standard Deviation (3y)
15.70%
as of May 31, 2026
Equity Beta (3y)
0.78
as of May 31, 2026
Unsubsidized 30-Day SEC Yield
0.44%
as of May 31, 2026

This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section.

More Funds to Consider

IDNA
iShares Genomics Immunology and Healthcare ETFView IDNA
THRO
iShares U.S. Thematic Rotation Active ETFView THRO

Holdings

Holdings are subject to change.


The values shown for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Holdings data shown reflects the investment book of record, which may differ from the accounting book of record used for the purposes of determining the Net Assets of the Fund. Notional value represents the portfolio's exposures based on the economic value of investments and options are delta-adjusted. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The calculated values may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent date for which a price is available and may not necessarily be as of the date shown above.

Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures.

“Quantity” represents the number of shares, units or contracts of the corresponding security, as applicable per security type.

Exposure Breakdowns

Sector
% of Market Value as of Jun 17, 2026
Health Care95.54%
Cash and/or Derivatives4.52%
Industrials0.00%
Information Technology0.00%

Allocations are subject to change.

Ratings

Bronze Medal
Morningstar Medalist Rating
Effective Apr 30, 2026
Morningstar has awarded the Fund a Bronze medal.
Analyst-Driven
Data Coverage

Performance

1y3y5y10yIncept.
Total Return (%)
19.197.200.59-2.57
Market Price (%)
19.357.280.56-2.60
After Tax Pre-Liq. (%)
19.197.190.58-2.57
After Tax Post-Liq. (%)
11.365.570.45-1.98

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

Performance shown reflects fee waivers and/or expense reimbursements by the investment advisor to the fund for some or all of the periods shown. Performance would have been lower without such waivers.

The ETF total return may appear to diverge from the return of its benchmark. This may be due to the use of systematic fair value. Click here for more information

Growth of Hypothetical $10,000
-

The Hypothetical Growth of $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be found in the Performance section.

Distributions

Jun 15, 2026Jun 15, 2026Jun 18, 2026$0.081180$0.081180$0.000000$0.000000$0.000000
Dec 16, 2025Dec 16, 2025Dec 19, 2025$0.000000$0.000000$0.000000$0.000000$0.000000
Jun 16, 2025Jun 16, 2025Jun 20, 2025$0.000000$0.000000$0.000000$0.000000$0.000000
Dec 17, 2024Dec 17, 2024Dec 20, 2024$0.000000$0.000000$0.000000$0.000000$0.000000
Jun 11, 2024Jun 11, 2024Jun 17, 2024$0.000000$0.000000$0.000000$0.000000$0.000000
Dec 21, 2023Dec 20, 2023Dec 27, 2023$0.007207$0.007207$0.000000$0.000000$0.000000
Jun 08, 2023Jun 07, 2023Jun 13, 2023$0.000000$0.000000$0.000000$0.000000$0.000000
Dec 14, 2022Dec 13, 2022Dec 19, 2022$0.000000$0.000000$0.000000$0.000000$0.000000
Jun 10, 2022Jun 09, 2022Jun 15, 2022$0.000000$0.000000$0.000000$0.000000$0.000000
Dec 14, 2021Dec 13, 2021Dec 17, 2021$0.000000$0.000000$0.000000$0.000000$0.000000
Showing 1 to 10 of 12

Portfolio Managers

Fees

as of current prospectus
Management Fee
0.77%
Acquired Fund Fees and Expenses
0.00%
Other Expenses
+0.00%

Expense Ratio
0.77%
Fee Waivers
-0.22%

Net Expense Ratio
0.55%

The amounts shown above are as of the current prospectus, but may not include extraordinary expenses incurred by the Fund over the past fiscal year. Amounts are rounded to the nearest basis point, which in some cases may be "0.00".

ESG Integration

The Fund manager includes ESG considerations in combination with other information in the research and decision phases of the investment process. The Fund manager conducts regular portfolio reviews between with the Risk and Quantitative Analysis group and with the Chief Investment Officers. Where appropriate, these reviews include discussion of the portfolio's exposure to material ESG risks, as well as exposure to sustainability-related business involvements, climate-related metrics, and other factors.

This fund does not seek to follow a sustainable, impact or ESG investment strategy. For more information regarding the fund's investment strategy, please see the fund's prospectus or, as applicable, shareholder report.